You are here
- Home
Total number of clinical trials
- collapse Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD)
- collapse Efficacy and Safety Study or Fostamatinib Disodium Tablets to Treat B-cell Lymphoma
- collapse AZD2115 Single Ascending Dose Study
- collapse An Open, Non-controlled, Non-randomised, Parallel-group Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of AZD8848 Administered Intranasally to Male and Female Butyrylcholinesterase Deficient Subjects and to Sex and Age Matched Controls
- collapse An Open-Label, Non-Randomised, 2-Period, Single Centre Study to Assess the Pharmacokinetics of Digoxin in Healthy Subjects when Administered Alone and in Combination with Fostamatinib 100 mg Twice Daily
- collapse A Phase I, Single centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses of AZD8075 in Healthy Male Volunteers
- collapse An Open-Label. Phase I Study to Assess the Excretion of Radioactivity, Metabolic Profiles and Pharmacokinetics folloiwing a Single Oral Dose of 60 mg of [14C] AZD1236 in Healthy Male Subjects
- collapse A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Phase II study to Assess the Efficacy of 28 Day Oral Administration of AZD1236 in Adult Patients with Cystic Fibrosis
- collapse A Phase I, Open Label, Multicenter Study to Assess the Safety, Tolerability and Pharmacology of AZD2281 in Combination with Liposomal Doxorubicin (Caelyx) in Patients with Advanced Solid Tumors
- collapse Bioequivalence of Bicalutamide new formulation in Japane
